NCT06936306

Brief Summary

The goal of this clinical trial is to evaluate whether the Guided Biofilm Therapy (GBT) protocol can improve or maintain oral health and whether it provides more comfort to patients compared to a conventional protocol. The study involved 25 adult patients aged 18 years or older, healthy, unmedicated, with more than 20 natural teeth, and no periodontitis. Main Questions it Aims to Answer:

  • Does the GBT protocol improve or maintain oral health compared to a conventional protocol?
  • Is the GBT protocol more comfortable for patients than the conventional protocol? Comparison Group: Researchers compared the conventional protocol (used in quadrants I and III for Group A, and in quadrants II and IV for Group B) to the test GBT protocol (used in the opposite quadrants) to see if the GBT protocol results in improved clinical outcomes and better patient comfort. Participants Will:
  • Undergo two different protocols for oral prophylaxis (GBT and conventional protocols) on separate quadrants of their mouth.
  • Have their clinical parameters assessed at three time points: baseline (T0), one week (T1), and three weeks (T2) after the intervention.
  • Rate the comfort of the intervention using a Visual Analog Scale (VAS) on a Likert scale from 0 to 10 for each quadrant.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 17, 2022

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 29, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

November 30, 2024

Completed
5 months until next milestone

First Posted

Study publicly available on registry

April 20, 2025

Completed
Last Updated

April 24, 2025

Status Verified

April 1, 2025

Enrollment Period

1 month

First QC Date

November 30, 2024

Last Update Submit

April 19, 2025

Conditions

Keywords

Guided Biofilm TherapyDental plaqueOral HygieneAir PolishingConfortBiofilm disclosing

Outcome Measures

Primary Outcomes (1)

  • GBI

    Ainamo \& Bay gingival bleeding index

    4 weeks

Secondary Outcomes (2)

  • PCR

    4 weeks

  • PI

    4 weeks

Study Arms (2)

Test

EXPERIMENTAL

GBT Protocol

Procedure: GBTDevice: Master

Control

ACTIVE COMPARATOR

Scalling and polishing

Procedure: scalling

Interventions

GBTPROCEDURE

GBT Protocol

Also known as: GBT Protocol
Test
MasterDEVICE

Use master piezon

Test
scallingPROCEDURE

scalling

Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • healthy, unmedicated, without periodontitis, and with more than 20 natural teeth

You may not qualify if:

  • dental implants, with periodontal pockets equal to or greater than 4, with fixed orthodontic appliances, with special needs, with some medical pathology, taking antibiotics 3 months before the study, smokers, with known hypersensitivity to erythritol and patients who did not complete the follow-up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Lisbon

Lisbon, Portugal

Location

MeSH Terms

Conditions

Dental PlaqueGingival Hemorrhage

Condition Hierarchy (Ancestors)

Dental DepositsTooth DiseasesStomatognathic DiseasesOral HemorrhageMouth DiseasesGingival DiseasesPeriodontal DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 30, 2024

First Posted

April 20, 2025

Study Start

March 17, 2022

Primary Completion

April 29, 2022

Study Completion

October 1, 2022

Last Updated

April 24, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations